scispace - formally typeset
J

Joyce J. Repa

Researcher at University of Texas Southwestern Medical Center

Publications -  100
Citations -  24047

Joyce J. Repa is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Liver X receptor & Cholesterol. The author has an hindex of 54, co-authored 100 publications receiving 22419 citations. Previous affiliations of Joyce J. Repa include University of Wisconsin System & University of Wisconsin-Madison.

Papers
More filters
Journal ArticleDOI

Identification of a Nuclear Receptor for Bile Acids

TL;DR: Results presented here show that bile acids are physiological ligands for the farnesoid X receptor (FXR), an orphan nuclear receptor, which demonstrates a mechanism by which bile acid transcriptionally regulate their biosynthesis and enterohepatic transport.
Journal ArticleDOI

Nuclear receptors and lipid physiology: opening the X-files.

TL;DR: Some general principles that govern the actions of this class of bioactive lipids and their nuclear receptors are considered here, and the scheme that emerges reveals a complex molecular script at work.
Journal ArticleDOI

Role of LXRs in control of lipogenesis

TL;DR: The identification here of a synthetic, nonsteroidal LXR-selective agonist series represented by T0314407 and T0901317 revealed a novel physiological role of LXR, and suggested that the increase in plasma lipids occurs via NXR-mediated induction of the sterol regulatory element-binding protein 1 (SREBP-1) lipogenic program.
Journal ArticleDOI

Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ

TL;DR: A novel LXR target is described, the sterol regulatory element-binding protein-1c gene (SREBP-1C), which encodes a membrane-bound transcription factor of the basic helix-loop-helix-leucine zipper family and reveals a unique regulatory interplay between cholesterol and fatty acid metabolism.
Journal ArticleDOI

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis

TL;DR: It is demonstrated that fibroblast growth factor 15 signals from intestine to liver to repress the gene encoding cholesterol 7alpha-hydroxylase (CYP7A1), which catalyzes the first and rate-limiting step in the classical bile acid synthetic pathway.